| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 108.809 | 78.081 | 3.434 | 502 | 1.644 | 849 | 1.564 | 42.162 | 468.044 | 846.305 |
| Total Income - EUR | 109.246 | 78.089 | 5.797 | 502 | 3.383 | 901 | 3.356 | 42.249 | 468.813 | 847.618 |
| Total Expenses - EUR | 105.881 | 89.862 | 11.292 | 5.940 | 12.420 | 30.574 | 10.425 | 63.884 | 421.004 | 842.157 |
| Gross Profit/Loss - EUR | 3.365 | -11.773 | -5.495 | -5.438 | -9.037 | -29.674 | -7.069 | -21.635 | 47.809 | 5.461 |
| Net Profit/Loss - EUR | 2.584 | -11.773 | -5.561 | -5.453 | -9.159 | -29.677 | -7.106 | -22.058 | 41.367 | 3.264 |
| Employees | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 4 |
Check the financial reports for the company - Da&Za Pharmachem Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 998 | 988 | 971 | 953 | 991 | 0 | 0 | 0 | 454 | 35.428 |
| Current Assets | 44.978 | 18.392 | 13.919 | 12.988 | 15.349 | 11.787 | 15.080 | 17.003 | 122.154 | 126.696 |
| Inventories | 15.779 | 6.870 | 6.083 | 5.782 | 8.130 | 3.486 | 6.742 | 10.362 | 56.152 | 63.040 |
| Receivables | 25.436 | 11.216 | 6.818 | 7.097 | 7.046 | 7.484 | 7.410 | 3.112 | 27.172 | 30.394 |
| Cash | 3.763 | 306 | 1.018 | 109 | 173 | 818 | 927 | 3.529 | 38.830 | 33.262 |
| Shareholders Funds | -10.384 | -22.050 | -27.238 | -32.262 | -40.796 | -69.700 | -75.260 | -97.551 | -55.889 | -52.313 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 56.359 | 41.583 | 42.128 | 46.203 | 57.136 | 81.487 | 90.340 | 114.555 | 178.497 | 214.436 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Da&Za Pharmachem Srl